Clinical Trials Logo

3rd Line GIST clinical trials

View clinical trials related to 3rd Line GIST.

Filter by:
  • None
  • Page 1

NCT ID: NCT01735968 Active, not recruiting - 3rd Line GIST Clinical Trials

A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients

Start date: February 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine a maximum tolerated dose and/or recommended phase 2 dose of a combination of imatinib and BYL719 in the treatment of 3rd line GIST patients.

NCT ID: NCT01468688 Completed - 3rd Line GIST Clinical Trials

A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

Start date: April 20, 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine a maximum tolerated dose and/or recommended phase 2 dose of a combination of imatinib and BKM120 in the treatment of 3rd line GIST patients.